Joseph A. O’Donoghue

6.6k total citations
129 papers, 4.4k citations indexed

About

Joseph A. O’Donoghue is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joseph A. O’Donoghue has authored 129 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Radiology, Nuclear Medicine and Imaging, 50 papers in Pulmonary and Respiratory Medicine and 29 papers in Oncology. Recurrent topics in Joseph A. O’Donoghue's work include Radiopharmaceutical Chemistry and Applications (63 papers), Medical Imaging Techniques and Applications (34 papers) and Cancer, Hypoxia, and Metabolism (28 papers). Joseph A. O’Donoghue is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (63 papers), Medical Imaging Techniques and Applications (34 papers) and Cancer, Hypoxia, and Metabolism (28 papers). Joseph A. O’Donoghue collaborates with scholars based in United States, United Kingdom and Germany. Joseph A. O’Donoghue's co-authors include John L. Humm, T. E. Wheldon, Steven M. Larson, Neeta Pandit‐Taskar, Pat Zanzonico, Jason S. Lewis, Charlotte Ling, Chaitanya Divgi, Shutian Ruan and Serge K. Lyashchenko and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Joseph A. O’Donoghue

128 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph A. O’Donoghue United States	41	2.9k	1.3k	1.2k	965	766	129	4.4k
Pat Price United Kingdom	31	2.7k 0.9×	1.3k 1.0×	1.0k 0.8×	1.0k 1.1×	935 1.2×	111	4.8k
Joseph G. Rajendran United States	29	2.0k 0.7×	1.1k 0.8×	902 0.8×	858 0.9×	398 0.5×	74	3.8k
Katherine A. Vallis United Kingdom	40	1.8k 0.6×	1.0k 0.8×	1.4k 1.2×	864 0.9×	1.4k 1.9×	154	4.6k
Yvette L. Kasamon United States	34	2.3k 0.8×	1.1k 0.8×	2.1k 1.8×	371 0.4×	620 0.8×	99	5.9k
Ganesan Vaidyanathan United States	37	2.6k 0.9×	702 0.5×	1.1k 0.9×	350 0.4×	1.0k 1.3×	128	3.9k
Andrei Iagaru United States	41	2.9k 1.0×	2.1k 1.6×	1.3k 1.1×	402 0.4×	439 0.6×	253	5.0k
Stewart Kroll United States	29	1.8k 0.6×	945 0.7×	1.3k 1.0×	381 0.4×	596 0.8×	71	4.0k
Neeta Pandit‐Taskar United States	44	2.8k 1.0×	1.7k 1.3×	2.2k 1.8×	712 0.7×	878 1.1×	215	6.0k
Françoise Kraeber‐Bodéré France	40	2.7k 0.9×	1.0k 0.8×	1.4k 1.1×	292 0.3×	713 0.9×	215	4.9k
Jeffrey Y.C. Wong United States	43	2.7k 0.9×	1.8k 1.3×	1.5k 1.2×	374 0.4×	934 1.2×	214	5.4k

Countries citing papers authored by Joseph A. O’Donoghue

Since Specialization

Citations

This map shows the geographic impact of Joseph A. O’Donoghue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. O’Donoghue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. O’Donoghue more than expected).

Fields of papers citing papers by Joseph A. O’Donoghue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. O’Donoghue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. O’Donoghue. The network helps show where Joseph A. O’Donoghue may publish in the future.

Co-authorship network of co-authors of Joseph A. O’Donoghue

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. O’Donoghue. A scholar is included among the top collaborators of Joseph A. O’Donoghue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. O’Donoghue. Joseph A. O’Donoghue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ulaner, Gary A., et al.. (2025). ⁶¹ Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of ⁶¹ Cu-labeled PET Radiotracers. Radiology. 317(3). e251151–e251151.

Imber, Brandon S., Lisa Bodei, John L. Humm, et al.. (2023). A Pilot Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for Oligometastatic Hormone Sensitive Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e112–e112. 2 indexed citations

Lumish, Melissa, Steven B. Maron, Viktoriya Paroder, et al.. (2022). Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using⁸⁹Zr-Trastuzumab PET: A Pilot Study. Journal of Nuclear Medicine. 64(5). 724–730. 14 indexed citations

Krebs, Simone, Christian Grommes, Michael R. McDevitt, et al.. (2021). [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 783–785. 6 indexed citations

Schöder, Heiko, Paula Demétrio De Souza França, Reiko Nakajima, et al.. (2020). Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer. Clinical Cancer Research. 26(13). 3110–3116. 48 indexed citations

Lohrmann, Christian, Eileen M. O’Reilly, Joseph A. O’Donoghue, et al.. (2019). Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer. Clinical Cancer Research. 25(23). 7014–7023. 48 indexed citations

Reidy‐Lagunes, Diane, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, et al.. (2019). Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan. Clinical Cancer Research. 25(23). 6939–6947. 71 indexed citations

Carrasquillo, Jorge A., Patrick G. Morris, John L. Humm, et al.. (2019). Copper-64 trastuzumab PET imaging: a reproducibility study. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(2). 191–198. 22 indexed citations

Ulaner, Gary A., Serge K. Lyashchenko, Christopher C. Riedl, et al.. (2017). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. Journal of Nuclear Medicine. 59(6). 900–906. 141 indexed citations

10.

Kim, Kwanghee, Hanwen Zhang, Pooja Desai, et al.. (2017). Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy. Clinical Cancer Research. 23(13). 3343–3351. 16 indexed citations

11.

Dauer, Lawrence T., Matthew J. Williamson, John L. Humm, et al.. (2014). Radiation Safety Considerations for the Use of 223RaCl2 DE in Men with Castration-resistant Prostate Cancer. Health Physics. 106(4). 494–504. 57 indexed citations

12.

Schwartz, Jazmin, John L. Humm, Chaitanya Divgi, Steven M. Larson, & Joseph A. O’Donoghue. (2012). Bone Marrow Dosimetry Using ¹²⁴I-PET. Journal of Nuclear Medicine. 53(4). 615–621. 23 indexed citations

13.

Li, Xiao‐Feng, Sean Carlin, Muneyasu Urano, et al.. (2007). Visualization of Hypoxia in Microscopic Tumors by Immunofluorescent Microscopy. Cancer Research. 67(16). 7646–7653. 100 indexed citations

14.

Pugachev, Andrei, Filip Claus, Xiaoming Sun, et al.. (2005). Validation of PET hypoxia tracers by autoradiography and fluorescent microscopy. Medical Physics. 32(6). 2055–2055. 1 indexed citations

15.

O’Donoghue, Joseph A.. (2004). Relevance of External Beam Dose–Response Relationships to Kidney Toxicity Associated with Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 378–387. 34 indexed citations

16.

O’Donoghue, Joseph A., et al.. (2002). Hematologic Toxicity in Radioimmunotherapy: Dose-Response Relationships for I-131 Labeled Antibody Therapy. Cancer Biotherapy and Radiopharmaceuticals. 17(4). 435–443. 45 indexed citations

17.

Adelstein, S. James, Roger W. Howell, John L. Humm, et al.. (2002). 5 Techniques and Procedures. Journal of the ICRU. 2(1). 71–85. 2 indexed citations

18.

Adelstein, S. James, Roger W. Howell, John L. Humm, et al.. (2002). Absorbed-Dose Specification in Nuclear Medicine: Abstract. Journal of the ICRU. 2(1). 9–9. 7 indexed citations

19.

O’Donoghue, Joseph A.. (1994). The Impact of Tumor Cell Proliferation in Radioimmunotherapy. Cancer. 73(S3). 974–980. 24 indexed citations

20.

Wheldon, T. E. & Joseph A. O’Donoghue. (1990). The Radiobiology of Targeted Radiotherapy. International Journal of Radiation Biology. 58(1). 1–21. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact